Aequus Pharmaceuticals (FRA:AEQ) 5-Year Share Buyback Ratio : -9.00% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Aequus Pharmaceuticals 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Aequus Pharmaceuticals's current 5-Year Share Buyback Ratio was -9.00%.

FRA:AEQ's 5-Year Share Buyback Ratio is ranked worse than
73.6% of 712 companies
in the Drug Manufacturers industry
Industry Median: -2.9 vs FRA:AEQ: -9.00

Competitive Comparison of Aequus Pharmaceuticals's 5-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aequus Pharmaceuticals's 5-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Aequus Pharmaceuticals 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Aequus Pharmaceuticals (FRA:AEQ) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Aequus Pharmaceuticals 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (FRA:AEQ) » Definitions » 5-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

AQSZF:USA AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products namely Tacrolimus IR and Vistitan.

Aequus Pharmaceuticals Headlines

No Headlines